KOD Kodiak Sciences Inc.
Q3 2025 10-Q
Filed: Nov 13, 2025Period ending Sep 30, 2025
Health Care
Biological Products, (No Diagnostic Substances)SEC EDGAR Kodiak Sciences Inc. (KOD) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 13, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ3 2025 10-Q
Risk Factors
- • New risk: macroeconomic uncertainties including inflation, tariffs, rising interest rates, and bank failures impacting liquidity and operations
- • Updated risk: operational spend increased to $105.9 million for nine months ended Sept 30, 2025, cash used in operating activities $96.6 million vs $87.2 million prior year
Get deeper insights on Kodiak Sciences Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.